Anesthesia: Page 37

Pierrel introduces purer form of articaine
By DrBicuspid.com staff writers
Pierrel Research USA, a subsidiary of Pierrel SpA, will officially launch its new Orabloc articaine product in the U.S. at the California Dental Association (CDA) spring meeting in Anaheim this week.
May 9, 2011
Study IDs root cause of local anesthetic-related NSDs
By Rob Goszkowski
Dentists should consider not using 4% concentration anesthetics in the trigeminal area after a data analysis found that high-concentration formulations are the root cause of most neurosensory disturbances (NSDs), Danish researchers report in the Journal of the American Dental Association.
May 4, 2011
2009 10 13 14 18 37 618 Injection 70
Corticosteroids during pregnancy not linked to orofacial clefts
By Rosemary Frei, MSc
Pregnant women who take potent topical corticosteroids just before and during pregnancy risk fetal growth restriction in their infants, but there is no risk of fetal orofacial clefts with any form of corticosteroid taken by pregnant women, a pair of studies has found.
May 3, 2011
2009 05 19 09 23 26 920 Pregnant Woman 70
Does azithromycin enhance perio treatment outcomes?
By Rabia Mughal
The adjunctive use of antibiotics such as metronidazole or amoxicillin during periodontal treatment has been shown to offer short-term benefits. But a new study has found that another antibiotic -- azithromycin -- does not appear to offer the same benefits when treating advanced periodontal disease.
May 1, 2011
2008 09 29 16 08 46 67 Thumbsupanddown
Children can be safely sedated by nonanesthesiologists
By Reuters Health
NEW YORK (Reuters Health) - Many specialties perform pediatric procedural sedation with no differences in major complication rates, according to findings published online today in Pediatrics.
April 24, 2011
Reuterslogo
Syringe cover takes the fear out of pediatric local anesthesia
By Rob Goszkowski
A unique syringe cover that looks more like a toy than a dental instrument makes administering local anesthesia to young patients less traumatic for them and easier for the dentist, according to the Brazilian researchers who developed it.
April 20, 2011
2011 04 20 14 36 31 605 Angelus Alligator Syringe Cover Thumb
Milestone Scientific revenues up, losses down in 2010
By DrBicuspid.com staff writers
Milestone Scientific reported revenues of $9.75 million for 2010 (end-December 31, 2010), up 14% from $8.55 million in the previous year.
April 7, 2011
FDA OKs new drug to treat thyroid cancer
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration (FDA) has approved vandetanib to treat adult patients with late-stage medullary thyroid cancer who are ineligible for surgery and whose disease is growing or causing symptoms.
April 6, 2011
Dentist anesthesiologists play key research role, study finds
By DrBicuspid.com staff writers
While only 1.5% of dentists who contribute to research in dental anesthesiology are trained dental anesthesiologists (DAs), they are responsible for 10% of the publications, according to a new study in Anesthesia Progress that sought to determine how actively DAs contribute to research and new knowledge in the field of dental anesthesiology.
April 4, 2011
Is general anesthesia safe for younger brains?
By Rob Goszkowski
New research has called into question the effects of anesthesia on the brains of young children and sparked a call for greater understanding about potential long-term neurological consequences, according to an article in the New England Journal of Medicine.
April 3, 2011
2011 01 25 11 23 22 743 I Vsedation2 70
Buccal beats lingual for numbing first molars
By DrBicuspid.com staff writers
Buccal infiltration is more effective than lingual infiltration in obtaining anesthesia of the first mandibular molar and premolar teeth, according to researchers from the Newcastle University School of Dental Sciences.
March 31, 2011
NIH awards $2M grant for oral mucositis treatment
By DrBicuspid.com staff writers
Biotech firm Synedgen has been awarded a $1.96 million phase II Small Business Innovation Research grant by the National Institutes of Health (NIH) to accelerate the development of Synedgen's proprietary oral disease treatments.
March 22, 2011
Previous Page
Page 37 of 56
Next Page